Stock AEMD AETHLON MEDICAL, INC.
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

Press Releases Aethlon Medical, Inc. OTC Bulletin Board

Equities

AEMD

US00808Y1091

Press Releases

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Aethlon Medical Announces Pricing of $4.7 Million Public Offering
PR
Aethlon Medical Reports Positive Results from an In Vitro Binding Study of Its Hemopurifier in Removing Extracellular Vesicles from Cancer Patient Plasma
AQ
Aethlon Medical Reports Positive Results From an In Vitro Binding Study of Its Hemopurifier® in Removing Extracellular Vesicles From Cancer Patient Plasma
PR
Aethlon Medical : Corporate Overview – May 2024
PU
Aethlon Medical : Corporate Presentation April 2024
PU
Aethlon Medical Enters Into Materials Transfer Agreement for Santersus AG's NucleoCapture and HemoNucleoCapture Devices
PR
Aethlon Medical Announces Fiscal Third Quarter Financial Results and Provides Corporate Update
PR
Aethlon Medical to Release Fiscal Third Quarter Financial Results and Host Conference Call on February 14, 2024
PR
Aethlon Medical Announces Fiscal Second Quarter Financial Results and Provides Corporate Update
PR
Aethlon Medical Announces Appointment of James B. Frakes, M.B.A. as Interim Chief Executive Officer and Guy Cipriani, M.B.A. as Chief Operating Officer
PR
Aethlon Medical to Release Second Quarter Financial Results and Host Conference Call on November 14, 2023
PR
Aethlon Announces Reverse Stock Split
PR
Aethlon Medical : September 2023 Aethlon Presentation for HC Wainwright Financial Conference
PU
Aethlon Medical to Present at the H.C. Wainwright 25th Annual Global Investment Conference
PR
Aethlon Medical to Release First Quarter Financial Results and Host Conference Call on August 10, 2023
PR
Aethlon Medical Signs Collaboration Agreement with 34 Lives to Evaluate the Ability of the Hemopurifier® to Expand the Utility of Unused, Donated Kidneys for Transplant
PR
Aethlon Medical Appoints Medical Device and Biomedical Executive, Nicolas Gikakis, to its Board of Directors
PR
Aethlon Medical to Release Fourth Quarter and Year End Financial Results and Host Conference Call on June 28, 2023
PR
Aethlon Medical Announces Investigation of the Hemopurifier® for Use in Organ Transplantation
PR
Aethlon Medical to Participate in the Healthcare Virtual Conference Presented by Maxim Group and Hosted by M-Vest
PR
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. AEMD Stock
  4. AEMD Stock
  5. News Aethlon Medical, Inc.
  6. Press Releases